Global Peri-implantitis Treatment Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Method Type;

Surgical Treatment, Mechanical Debridement, Laser Debridement, Open Flap Debridement, Open Flap Debridement With Guided Bone Generation, Non Surgical Treatment, Surface Debridement, Antibiotics ( Chlorhexidine Digluconate ), and Others.

By End User;

Hospitals and Dental Clinics.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn351556790 Published Date: November, 2024 Updated Date: December, 2024

Introduction

Global Peri-implantitis Treatment Market (USD Million), 2020 - 2030

In the year 2023, the Global Peri-implantitis Treatment Market was valued at USD 931.16 million. The size of this market is expected to increase to USD 1,669.68 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 8.7%.

Peri-implantitis is a pathological condition affecting the tissues surrounding dental implants, characterized by inflammation and the progressive loss of supporting bone. As dental implants have become an increasingly common solution for tooth replacement, the prevalence of peri-implantitis has also risen, leading to a growing demand for effective treatment solutions. The global peri-implantitis treatment market encompasses a range of products and procedures aimed at managing this condition, including mechanical debridement, antimicrobial treatments, surgical interventions, and regenerative procedures. This market is driven by the rising incidence of peri-implantitis, advancements in dental technology, and an increasing awareness of oral health.

The market is segmented based on treatment type, end-user, and geography. Treatment types include non-surgical and surgical therapies, each offering distinct approaches to managing peri-implantitis. Non-surgical treatments often involve mechanical cleaning and the use of antiseptics, while surgical options may include resective surgery, bone regeneration techniques, and the use of laser therapy. End-users of these treatments are primarily dental clinics, hospitals, and academic and research institutions, each playing a crucial role in the diagnosis and management of peri-implantitis. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and other regions, with varying degrees of market penetration and growth potential in each area.

North America and Europe currently dominate the global peri-implantitis treatment market, attributed to the high prevalence of dental implants and advanced healthcare infrastructure. These regions benefit from well-established dental care systems, high disposable incomes, and a strong focus on research and development in dental health. In contrast, the Asia-Pacific region is expected to witness significant growth in the coming years. This growth is driven by increasing dental tourism, rising healthcare expenditure, and a growing awareness of dental health. Additionally, the expanding middle-class population and improving healthcare facilities in countries like China and India contribute to the market's growth potential in this region.

The competitive landscape of the global peri-implantitis treatment market features a mix of established players and emerging companies. Leading companies are focusing on strategic initiatives such as mergers and acquisitions, product launches, and collaborations to strengthen their market position. Innovation is a key driver, with ongoing research aimed at developing more effective and less invasive treatment options. As the prevalence of peri-implantitis continues to rise, the market is poised for sustained growth, offering numerous opportunities for companies operating in this space to expand their product offerings and enhance patient outcomes.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Method Type
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
  4. Global Peri-implantitis Treatment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of dental implants
        2. Rising awareness about oral health
        3. Advances in dental technology
      2. Restraints
        1. High cost of treatment
        2. Lack of skilled professionals
        3. Limited insurance coverage
      3. Opportunities
        1. Growing aging population
        2. Increasing demand for cosmetic dentistry
        3. Technological innovations in treatment methods
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Peri-implantitis Treatment Market, By Method Type 2020 - 2030 (USD Million)
      1. Surgical Treatment
        1. Mechanical Debridement
        2. Laser Debridement
        3. Open Flap Debridement
        4. Open Flap Debridement with guided bone generation.
      2. Non Surgical Treatment
        1. Surface Debridement
        2. Antibiotics ( Chlorhexidine Digluconate )
        3. Others
    2. Global Peri-implantitis Treatment Market, By End User, 2020 - 2030 (USD Million)
      1. Hospitals
      2. Dental Clinics
    3. Global Peri-implantitis Treatment Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Straumann Holding AG
      2. Nobel Biocare Services AG (Part of Danaher Corporation)
      3. Dentsply Sirona Inc.
      4. Zimmer Biomet Holdings, Inc.
      5. BioHorizons IPH, Inc. (Part of Henry Schein, Inc.)
      6. OraPharma, Inc. (Part of Bausch Health Companies Inc.)
      7. Sunstar Suisse S.A.
      8. GalvoSurge Dental AG
      9. MegaGen Implant Co., Ltd.
      10. Geistlich Pharma AG
  7. Analyst Views
  8. Future Outlook of the Market